Roger Hajjar

Roger Hajjar

Company: AskBio

Job title: Therapeutic Sector Leader, Cardiac Gene Therapy


Targeting Cardiac Muscle 8:00 am

Cardiac specific delivery of vectors has been achieved using minimally invasive techniques clinically AAV vectors have been used safely in early cardiac gene therapies, but myocardial uptake has been inefficient so far Novel re-engineered AAV vectors are increasing the efficiency of myocardial uptake The scope of cardiac diseases that is being targeted by gene therapy…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.